Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zavesca PK and Safety in Infantile GM2 Gangliosidosis
NCT00672022Phase 3Completed
- Sponsor
- Children's National Research Institute
- Start
- Jul 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of miglustat in GM2 gangliosidosis, sponsored by Children's National Research Institute. Started Jul 2004; status: completed.
02
Drugs
miglustat
03
Conditions
GM2 gangliosidosis
Beyond the preview
Go deeper on NCT00672022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672022.